TD Securities Forecasts Strong Price Appreciation for Vitalhub (TSE:VHI) Stock

Vitalhub (TSE:VHI) had its price target increased by research analysts at TD Securities from C$13.00 to C$14.00 in a report issued on Monday,BayStreet.CA reports. The firm currently has a “buy” rating on the stock. TD Securities’ price target points to a potential upside of 39.17% from the stock’s previous close.

VHI has been the topic of several other research reports. Raymond James set a C$13.50 price objective on shares of Vitalhub and gave the company an “outperform” rating in a research report on Thursday. Scotiabank set a C$14.00 price objective on Vitalhub and gave the stock an “outperform” rating in a report on Thursday, January 30th. Finally, Canaccord Genuity Group increased their price objective on shares of Vitalhub from C$12.00 to C$12.50 and gave the company a “buy” rating in a research note on Thursday, January 16th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has an average rating of “Buy” and an average target price of C$12.08.

Vitalhub Stock Down 1.8 %

VHI traded down C$0.18 during mid-day trading on Monday, reaching C$10.06. 100,509 shares of the company traded hands, compared to its average volume of 145,951. The stock has a market capitalization of C$544.17 million, a P/E ratio of 163.62, a P/E/G ratio of 1.18 and a beta of 1.26. Vitalhub has a 52-week low of C$5.80 and a 52-week high of C$12.09. The company’s fifty day moving average price is C$10.48 and its 200-day moving average price is C$10.35.

About Vitalhub

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.